GMRE Global Medical REIT Inc

  1. Stocks
  2. Real Estate
  3. NYSE: GMRE

Price (delayed)

$8.4

Market cap

$550.83M

P/E Ratio

36.52

Dividend/share

$0.84

EPS

$0.23

Enterprise value

$1.16B

Global Medical REIT Inc. is a net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market ...

Highlights
The stock's price to earnings (P/E) is 15% less than its last 4 quarters average of 43.0
GMRE's debt is down by 12% YoY
The EPS rose by 15% year-on-year but it has declined by 4.2% since the previous quarter
The company's net income rose by 8% YoY but it fell by 6% QoQ
The equity has declined by 8% year-on-year and by 4.6% since the previous quarter
Sector: Real Estate
Industry: REIT - Healthcare Facilities
Website: http://www.globalmedicalreit.com

Key stats

What are the main financial stats of GMRE
Market
Shares outstanding
65.57M
Market cap
$550.83M
Enterprise value
$1.16B
Valuations
Price to earnings (P/E)
36.52
Price to book (P/B)
0.94
Price to sales (P/S)
3.9
EV/EBIT
22.43
EV/EBITDA
12.45
EV/Sales
8.19
Earnings
Revenue
$141.05M
EBIT
$51.51M
EBITDA
$92.77M
Free cash flow
$137.31M
Per share
EPS
$0.23
Free cash flow per share
$2.09
Book value per share
$8.9
Revenue per share
$2.15
TBVPS
$19.25
Balance sheet
Total assets
$1.27B
Total liabilities
$661.89M
Debt
$611.23M
Equity
$583.58M
Working capital
N/A
Liquidity
Debt to equity
1.05
Current ratio
N/A
Quick ratio
N/A
Net debt/EBITDA
6.52
Margins
EBITDA margin
65.8%
Gross margin
100%
Net margin
14.6%
Operating margin
26.9%
Efficiency
Return on assets
1.1%
Return on equity
2.4%
Return on invested capital
2.7%
Return on capital employed
N/A
Return on sales
36.5%
Dividend
Dividend yield
10%
DPS
$0.84
Payout ratio
365.2%

GMRE stock price

How has the Global Medical REIT stock price performed over time
Intraday
0.84%
1 week
3.58%
1 month
-1.52%
1 year
-7.39%
YTD
-24.32%
QTD
-4%

Financial performance

How have Global Medical REIT's revenue and profit performed over time
Revenue
$141.05M
Gross profit
$141.05M
Operating income
$37.94M
Net income
$20.61M
Gross margin
100%
Net margin
14.6%
The company's net income rose by 8% YoY but it fell by 6% QoQ
GMRE's net margin is up by 5% YoY but it is down by 3.3% QoQ
The operating margin is down by 3.9% year-on-year
GMRE's operating income is down by 3.8% since the previous quarter

Growth

What is Global Medical REIT's growth rate over time

Valuation

What is Global Medical REIT stock price valuation
GMRE P/E details
P/E
36.52
P/B
0.94
P/S
3.9
EV/EBIT
22.43
EV/EBITDA
12.45
EV/Sales
8.19
The EPS rose by 15% year-on-year but it has declined by 4.2% since the previous quarter
The stock's price to earnings (P/E) is 15% less than its last 4 quarters average of 43.0
The P/B is 22% lower than the 5-year quarterly average of 1.2 and 6% lower than the last 4 quarters average of 1.0
The equity has declined by 8% year-on-year and by 4.6% since the previous quarter
The stock's price to sales (P/S) is 37% less than its 5-year quarterly average of 6.2 and 11% less than its last 4 quarters average of 4.4
GMRE's revenue is up by 2.7% year-on-year but it is down by 2.3% since the previous quarter

Efficiency

How efficient is Global Medical REIT business performance
GMRE's return on invested capital is up by 23% year-on-year
The ROE has increased by 14% YoY but it has decreased by 8% QoQ
The return on sales rose by 13% year-on-year but it has declined by 2.1% since the previous quarter
GMRE's ROA is up by 10% YoY but it is down by 8% QoQ

Dividends

What is GMRE's dividend history
Dividend details
DPS
$0.84
Dividend yield
10%
Payout ratio
365.2%
Recent dividends

Financial health

How did Global Medical REIT financials performed over time
The company's total assets is 92% higher than its total liabilities
The total liabilities is down by 11% year-on-year
The company's total assets fell by 9% YoY and by 2.7% QoQ
GMRE's debt is 4.7% higher than its equity
GMRE's debt is down by 12% YoY
The equity has declined by 8% year-on-year and by 4.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.